跳至主要内容
临床试验/NCT02719041
NCT02719041Unknown不适用

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Responsive to IGF1R therapy

研究概览

简要总结

The main goal of this study is to employ a novel proteomic approach to identify predictive tumor biomarkers that will increase the efficacy of insulin-like growth factor (IGF1R) targeted therapy in epithelial ovarian cancer. It is expected that these predictive biomarkers will be applied to increase the response rate in selected groups of patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • women who underwent surgery for ovarian cancer

排除标准

  • 未提供

结局指标

主要结局

Responsive to IGF1R therapy

时间窗: One year

Mean tumor volume will be calculated and growth inhibition will be reported as the percentage decrease of tumor volume compared with the control.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验